Article
Transcriptomic Changes and Biomarkers in Barrett's Metaplasia, Dysplasia and Cancer
2026-08-25
Abstract excerpt
Esophageal adenocarcinoma (EAC) has a poor five-year survival rate and one of the fastest-rising incidences of any cancer. The presence of dysplasia in Barrett's esophagus (BE) is the main risk factor for EAC development and guides clinical management. Unfortunately, the current histopathological diagnosis of dysplasia is unreliable, with poor inter-observer agreement, highlighting the need for novel biomarkers th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eb8c5b0b-a5e4-53a9-a726-8483a5795d3c
- DOI
- 10.64898/2026.08.25.746910
